Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: JACC Cardiovasc Imaging. 2016 Apr 13;9(10):1131–1141. doi: 10.1016/j.jcmg.2015.11.024

Figure 2. Probability of CTRCD According to Treatment Regimen.

Figure 2

The predicted probabilities of CTRCD for doxorubicin (orange), doxorubicin followed by trastuzumab (purple), and trastuzumab (green).